Immunome, Inc.

IMNMNASDAQHealthcare● Active

$18.61

+$0.03(+0.16%)

Market Cap$1.8B

P/E Ratio—

52W High$27.65

52W Low$7.96

Avg Volume1.2M

Open$18.93

Beta2.07

Insider Trades Ownership Employees

Immunome, Inc. (IMNM) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · IMNM · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

1.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 50%Active transactions only · RSU vesting excluded50% Sell ↓

Immunome, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

IMNM insider buying and selling by quarter

IMNM insider selling · IMNM insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.0M1.0M0

2024 Q3

2024 Q4

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · IMNM ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

IMNM executive sell shares · IMNM board member insider trading · IMNM insider trading SEC filing

Showing 44 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 15, 2026	BIENAIME JEAN JACQUES Director	Purchase	5,000	$20.70	$104K	43,415	Form 4
Apr 2, 2026	Higgins Jack Chief Scientific Officer	Sale	9,438	$21.64	$204K	22,000	Form 4
Apr 2, 2026	Rosett Max CFO	Option	39,713	$1.35	$54K	119,037	Form 4
Apr 2, 2026	Rosett Max CFO	Option	31,848	$1.05	$33K	79,324	Form 4
Apr 2, 2026	Rosett Max CFO	Sale	63,656	$21.91	$1.39M⚡	55,381	Form 4
Apr 2, 2026	Rosett Max CFO	Sale	1,344	$22.48	$30K	54,037	Form 4
Mar 30, 2026	Higgins Jack Chief Scientific Officer	Gift	6,291	—	—	31,438	Form 4
Mar 27, 2026	SIEGALL CLAY B President and CEO · Director	Purchase	25,450	$19.67	$501K	690,704	Form 4
Mar 20, 2026	WAGENHEIM PHILIP Director	Sale	36,800	$20.47	$753K	369,347	Form 4
Mar 23, 2026	WAGENHEIM PHILIP Director	Sale	28,200	$20.65	$582K	341,147	Form 4
Mar 11, 2026	BIENAIME JEAN JACQUES Director	Purchase	1,000	$21.55	$22K	38,415	Form 4
Mar 10, 2026	BIENAIME JEAN JACQUES Director	Purchase	1,000	$22.12	$22K	37,415	Form 4
Dec 30, 2025	SIEGALL CLAY B President and CEO · Director	Purchase	4,729	$21.15	$100K	665,254	Form 4
Dec 22, 2025	Barchas Isaac Director	Sale	371,949	$21.72	$8.08M⚡	2,042,432	Form 4
Dec 22, 2025	Barchas Isaac Director	Sale	11,251	$22.34	$251K	2,031,181	Form 4
Dec 19, 2025	Higgins Jack Chief Scientific Officer	Gift	1,000	—	—	39,729	Form 4
Dec 19, 2025	Higgins Jack Chief Scientific Officer	Gift	1,000	—	—	38,729	Form 4
Dec 19, 2025	Higgins Jack Chief Scientific Officer	Gift	1,000	—	—	37,729	Form 4
Dec 19, 2025	Higgins Jack Chief Scientific Officer	Gift	1,000	—	—	1,000	Form 4
Dec 19, 2025	SIEGALL CLAY B President and CEO · Director	Purchase	7,278	$20.48	$149K	860,525	Form 4
Dec 19, 2025	SIEGALL CLAY B President and CEO · Director	Gift	200,000	—	—	660,525	Form 4
Dec 19, 2025	Tsai Philip Chief Technical Officer	Purchase	10,000	$20.49	$205K	43,300	Form 4
Dec 18, 2025	SIEGALL CLAY B President and CEO · Director	Purchase	46,511	$21.50	$1000K	853,247	Form 4
Sep 10, 2025	Higgins Jack Chief Scientific Officer	Option	22,000	$1.35	$30K	40,729	Form 4
Jun 3, 2025	BIENAIME JEAN JACQUES Director	Purchase	5,000	$9.38	$47K	36,415	Form 4

BIENAIME JEAN JACQUES

Director

Purchase

Date

May 15

5,000

Price

$20.70

Value

$104K

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Sale

Date

Apr 2

9,438

Price

$21.64

Value

$204K

View Form 4 on SEC.gov

Rosett Max

CFO

Option

Date

Apr 2

39,713

Price

$1.35

Value

$54K

View Form 4 on SEC.gov

Rosett Max

CFO

Option

Date

Apr 2

31,848

Price

$1.05

Value

$33K

View Form 4 on SEC.gov

Rosett Max

CFO

Sale

Date

Apr 2

63,656

Price

$21.91

Value

$1.39M ⚡

View Form 4 on SEC.gov

Rosett Max

CFO

Sale

Date

Apr 2

1,344

Price

$22.48

Value

$30K

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Gift

Date

Mar 30

6,291

Price

—

Value

—

View Form 4 on SEC.gov

SIEGALL CLAY B

President and CEO · Director

Purchase

Date

Mar 27

25,450

Price

$19.67

Value

$501K

View Form 4 on SEC.gov

WAGENHEIM PHILIP

Director

Sale

Date

Mar 20

36,800

Price

$20.47

Value

$753K

View Form 4 on SEC.gov

WAGENHEIM PHILIP

Director

Sale

Date

Mar 23

28,200

Price

$20.65

Value

$582K

View Form 4 on SEC.gov

BIENAIME JEAN JACQUES

Director

Purchase

Date

Mar 11

1,000

Price

$21.55

Value

$22K

View Form 4 on SEC.gov

BIENAIME JEAN JACQUES

Director

Purchase

Date

Mar 10

1,000

Price

$22.12

Value

$22K

View Form 4 on SEC.gov

SIEGALL CLAY B

President and CEO · Director

Purchase

Date

Dec 30

4,729

Price

$21.15

Value

$100K

View Form 4 on SEC.gov

Barchas Isaac

Director

Sale

Date

Dec 22

371,949

Price

$21.72

Value

$8.08M ⚡

View Form 4 on SEC.gov

Barchas Isaac

Director

Sale

Date

Dec 22

11,251

Price

$22.34

Value

$251K

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Gift

Date

Dec 19

1,000

Price

—

Value

—

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Gift

Date

Dec 19

1,000

Price

—

Value

—

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Gift

Date

Dec 19

1,000

Price

—

Value

—

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Gift

Date

Dec 19

1,000

Price

—

Value

—

View Form 4 on SEC.gov

SIEGALL CLAY B

President and CEO · Director

Purchase

Date

Dec 19

7,278

Price

$20.48

Value

$149K

View Form 4 on SEC.gov

SIEGALL CLAY B

President and CEO · Director

Gift

Date

Dec 19

200,000

Price

—

Value

—

View Form 4 on SEC.gov

Tsai Philip

Chief Technical Officer

Purchase

Date

Dec 19

10,000

Price

$20.49

Value

$205K

View Form 4 on SEC.gov

SIEGALL CLAY B

President and CEO · Director

Purchase

Date

Dec 18

46,511

Price

$21.50

Value

$1000K

View Form 4 on SEC.gov

Higgins Jack

Chief Scientific Officer

Option

Date

Sep 10

22,000

Price

$1.35

Value

$30K

View Form 4 on SEC.gov

BIENAIME JEAN JACQUES

Director

Purchase

Date

Jun 3

5,000

Price

$9.38

Value

$47K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About IMNM insider trading

IMNM insider trades

Immunome, Inc. (IMNM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Higgins Jack (Chief Scientific Officer), SIEGALL CLAY B (President and CEO · Director), Rosett Max (CFO). Over the past 12 months, 5 insiders have filed transactions with the SEC. IMNM insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Immunome, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

IMNM insider trading · 5 questions

The insiders of Immunome, Inc. (IMNM) include executives and directors such as Higgins Jack (Chief Scientific Officer), SIEGALL CLAY B (President and CEO · Director), Rosett Max (CFO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

IMNM board member insider tradingwho are IMNM insidersIMNM insider rosterImmunome, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026